Thaci, D.; Papp, K.; Gordon, K.; Morita, A.; Gooderham, M.; Foley, P.; Alemano, E.; Kisa, R.; Elbez, Y.; Ren, H.; Banerjee, S. An Oral, Selective Tyrosine Kinase 2 Inhibitor, BMS-986165, Improves Quality of Life in Psoriasis: Results from a Phase 2 Study. J of Skin 2019, 3, S12.